-
Bioenergy!
Time of Update: 2021-11-12
"We want to know how C3 and C4 plants respond to fluctuating light, because one of the limiting factors experienced by crops in farmland is the changing light due to overlapping leaf shade, wind or passing clouds, and changes in the angle of the sun throughout the day," Moonsub Lee, a postdoctoral researcher in Illinois, led a research project called "Using ultra-high-yield energy sugarcane to produce renewable oil" (ROGUE) .
-
The famous scholar Science released a new breakthrough in protein identification: scanning one protein and one amino acid at a time
Time of Update: 2021-11-12
A research team led by Cees Dekker, a distinguished university professor in the Department of Bio-Nanoscience at Delft University of Technology in the Netherlands, and an academician of the Royal Netherlands Academy of Arts and Sciences, has now released a new technology that can scan one protein and one amino acid at a time .
-
Unexpected types of antibodies found in people infected with malaria
Time of Update: 2021-11-12
In this new study, the research team looked at antibodies collected in the blood of 54 adult study participants infected with malaria in the laboratory, either through direct injections into the bloodstream or through mosquito bites .
-
Science Sub-Journal: Genes are related to the cognitive flexibility of the elderly
Time of Update: 2021-11-12
A new study by researchers from the Massachusetts Institute of Technology (MIT) shows that this enrichment appears to activate a gene family called MEF2, which controls genetic programs in the brain that promote resistance to cognitive decline .
-
One-time treatment maintains efficacy for up to one year, innovative gene therapy will enter Phase 3 clinical trials
Time of Update: 2021-11-12
On November 4, 2021, Sangamo Therapeutics announced that the gene therapy isaralgagene civaparvovec (ST-920) has obtained positive preliminary results in a phase 1/2 clinical trial in patients with Fabry disease .
-
Researcher Lu Jin’s research group from the School of Physics published a long article on the research review of sub-10 nm two-dimensional transistors in Physics Report
Time of Update: 2021-11-12
Due to the impact of the short channel effect, if the gate length continues to be shortened, the device performance will be greatly reduced, which has caused the semiconductor industry to worry about the failure of Moore's Law .
-
Oncogene: How Inflammation Causes Gastric Cancer
Time of Update: 2021-11-12
However, most importantly, they found that NOX1/ROS signaling causes uncontrollable proliferation of gastric epithelial stem cells, leading to tumor formation .
-
The nose of PNAS mammals comes from the jaws of reptiles
Time of Update: 2021-11-12
This research, recently published in the Proceedings of The National Academy of Sciences, is the first time that a cell study comparing multiple embryos of multiple species has been used to examine the evolution of facial structures .
-
Comprehensive protein interaction network helps researchers discover drug candidates for the treatment of COVID-19
Time of Update: 2021-11-12
Researchers from the University of Helsinki and the University of Eastern Finland first searched for suitable drug targets and reusable drugs, and finally discovered six antiviral effects against SARS-CoV-2 Candidate drugs .
-
Nature Sub-Journal: RAS Inhibitors Used to Treat More Cancers
Time of Update: 2021-11-12
The research, published in the journal Nature Structural & Molecular Biology, focuses on a family of proteins called RAS, which is used in all cancers, especially fatal cancers such as pancreatic cancer and colon.
-
A new solid tumor targeting model for bicyclic peptide coupled immunotherapy enters the clinic
Time of Update: 2021-11-12
Today, Bicycle Therapeutics announced that its tumor-targeted immune cell agonist BT7480, designed based on bicyclic peptides, has completed its first patient administration in a phase 1/2 clinical trial .
-
eLife: Researchers have successfully identified a protein in the coronavirus that can destroy blood vessels
Time of Update: 2021-11-12
Now, for the first time, a team of experts led by Tel Aviv University has been able to identify five of the 29 proteins that make up this blood vessel-damaging virus .
-
Phase 3 clinical results of ready-to-use T cell therapy positively and significantly improve patient survival
Time of Update: 2021-11-12
On November 4, 2021, Atara Biotherapeutics announced that T cell immunotherapy tabelecleucel (tab-cel) is a critical phase 3 in the treatment of EB virus (EBV)-related post-transplant lymphoproliferative disease (EBV+PTLD) Positive results in clinical trials .
-
Cambridge University "antivirus" air filtration system-innovative nanomaterials can eliminate viruses, including coronaviruses
Time of Update: 2021-11-12
The ultra-thin carbon nanotube conductive film, a new type of conductive filter film, is heated to a temperature above 100°C through resistance, so that viruses (including β-coronavirus) lose their activity within a few seconds, thereby achieving virus filtration and disinfection through hot flash .
-
How does a protein mutation of the tomato virus ToBRFV break through the resistance of tomatoes to tobacco viruses, a serious threat to the global tomato industry?
Time of Update: 2021-11-12
The main reason for the global ToBRFV outbreak is that this new virus overcomes all known tobacco virus resistance in tomatoes, including the resistance conferred by the gene Tm-2 2 , which has always had stable resistance to these viruses .
-
An important breakthrough in "Science": Directly read protein sequences with nanopore technology!
Time of Update: 2021-11-12
Today, a top academic journal published an important paper online-for the first time scientists have used nanopore technology to directly read protein sequences with a single amino acid resolution.
-
Counterintuitive?
Time of Update: 2021-11-12
Co-lead author Professor Stephen Moss (University College London Institute of Ophthalmology) said: "Although it is counterintuitive that finding a way to normalize cancer tumor blood vessels has become a clinical goal, identifying an effective treatment tool has been proven It is difficult to achieve .
-
One drug has the potential to curb multiple cancers
Time of Update: 2021-11-12
Westover’s laboratory has collaborated with the Dana-Farber Cancer Institute to develop a drug that binds to specific RAS mutants, the glycine at position 12 in the RAS mutant The amino acid is converted to cysteine, the so-called KRAS G12C .
-
Professor Li Yulong was invited to be interviewed by "Neuron" magazine and talked about the development of optical imaging tools and whole brain research
Time of Update: 2021-11-12
In the "Neuron" special issue published on November 3, 2021, Professor Li Yulong personally shared a number of important issues related to the development of optical imaging tools and the study of the whole brain in the form of question-and-answer interviews .
-
Whole-genome sequencing increases the diagnosis rate of rare diseases by nearly a third
Time of Update: 2021-11-12
A new study published today in the British Medical Journal (BMJ) brings hope to undiagnosed families and supports the establishment of a national diagnostic plan based on whole-genome sequencing (WGS) in the UK for faster diagnosis and more accurate diagnosis.
